Vendis Capital seals €290m Sylphar sale to EQT’s Karo Pharma

• Mike Didymus
• November 23, 2021

Vendis Capital has sealed a €290m sale of Belgian teeth, mouth and skincare products business Sylphar to EQT portfolio business Karo Pharma. The post Vendis Capital seals €290m Sylphar sale to EQT’s Karo Pharma first